Addleshaw Goddard Advises on $190M Alameda Healthcare Investment

Global law firm Addleshaw Goddard has played a key advisory role in a landmark financial transaction involving Alameda Healthcare, a top-tier private healthcare provider in Egypt. The firm assisted Alameda in securing a $190 million minority equity investment from Development Partners International (DPI), a London-based private equity group, alongside its co-investors. The agreement, primarily structured through a capital increase, is anticipated to reach completion by the third quarter of 2025, pending the usual regulatory clearances.

A Landmark Investment for Egypt’s Medical Sector

This deal stands out as the most significant private equity infusion into Egypt’s healthcare industry to date. It marks a pivotal chapter in Alameda’s growth journey while also solidifying DPI’s footprint in one of North Africa’s most dynamic markets. The funding is poised to fast-track Alameda’s broader expansion strategy, both within Egypt and across Gulf nations, aligning with its long-term goal of establishing Egypt as a regional centre for medical excellence.

Expanding Infrastructure and Clinical Capabilities

Alameda intends to channel the newly acquired capital into broadening its healthcare footprint. This will include scaling up its network of hospitals and outpatient facilities, integrating advanced medical technologies, and bolstering specialised Centres of Excellence in disciplines such as oncology, liver care, and cardiology. The investment will also fund programs designed to nurture local talent, helping to retain skilled Egyptian clinicians and counteract the emigration of medical expertise from the country.

A Pioneering Force in Egyptian Healthcare

Since its inception in 1999, Alameda has built a comprehensive ecosystem of healthcare services. Its portfolio includes renowned institutions like As-Salam International and Dar Al Fouad hospitals, a network of polyclinics, a rehabilitation centre, and Tabibi 24/7, a home healthcare provider. The group also offers laboratory diagnostics, pharmacy services, and other outpatient care facilities. Notably, Alameda is the only private healthcare group in Egypt to hold full Joint Commission International (JCI) accreditation for all its hospitals, underscoring its commitment to global healthcare standards and patient safety.

Philip Dowsett, Partner and Head of Investment Management and Funds at Addleshaw Goddard MENA, commented: “We are proud to have supported Alameda Healthcare on a transaction of such strategic significance. DPI’s investment reflects growing global confidence in Egypt’s healthcare infrastructure and Alameda’s leadership position within it. This deal also demonstrates our ability to advise on transformative cross-border investments that deliver regional impact.”

Legal Expertise Supporting Cross-Border Complexity

Addleshaw Goddard acted as the international legal advisor to Alameda throughout the course of the transaction. Their involvement encompassed key responsibilities such as structuring the deal, guiding investor negotiations, and navigating regulatory frameworks across several jurisdictions. The law firm’s counsel was instrumental in aligning all parties around a successful investment outcome.

Affirming Addleshaw Goddard’s Role in Emerging Market Investments

This transaction reinforces Addleshaw Goddard’s growing prominence in advising on sophisticated, high-value investments within healthcare, private equity, and emerging economies. With an expanding track record across the Middle East and Africa, the firm continues to deliver comprehensive legal support on deals that shape the region’s investment landscape.